Patents by Inventor William J. McClintock

William J. McClintock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5291202
    Abstract: In a noise radar a pseudo-random sequence is generated repeatedly and used to phase modulate a transmitted signal. The transmission is interrupted during a number of periods during each pseudo-random sequence which allows returns from targets to be received from the same antenna as is used for transmission during those periods of interruption. Each transmitted pulse, between successive periods of interruption, contains a different selection of successive digits of the code thus increasing the apparent randomness of the transmitted code and making detection more difficult.
    Type: Grant
    Filed: May 13, 1986
    Date of Patent: March 1, 1994
    Assignee: GEC Avionics Limited
    Inventor: William J. McClintock
  • Patent number: 5055461
    Abstract: Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a .beta.-aminopropiophenone, such as dyclonine HCl; (b) from about 0.02% to about 20% of saccharin; and (c) from about 1% to about 99% of a pharmaceutically acceptable oral carrier. Also provided are methods for providing an anesthetic effect in humans or animals which comprises orally administering to said human or animal a safe and effective amount of these pharmaceutical compositions. Also provided is a novel process for the manufacture of anesthetic lozenges containing a .beta.-aminopropiophenone along with saccharin.
    Type: Grant
    Filed: March 21, 1990
    Date of Patent: October 8, 1991
    Assignee: Richardson-Vicks Inc.
    Inventors: William J. Kelleher, William J. McClintock
  • Patent number: 4931473
    Abstract: Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a .beta.-aminopropiophenone, such as dyclonine HCl; (b) from about 0.02% to about 20% of saccharin; and (c) from about 1% to about 99% of a pharmaceutically acceptable oral carrier. Also provided are methods for providing an anesthetic effect in humans or animals which comprises orally administering to said human or animal a safe and effective amount of these pharmaceutically compositions. Also provided is a novel process for the manufacture of anesthetic lozenges containing a .beta.-aminopropiophenone along with saccharin.
    Type: Grant
    Filed: February 15, 1989
    Date of Patent: June 5, 1990
    Assignee: Richardson-Vicks Inc.
    Inventors: William J. Kelleher, William J. McClintock